Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection

American Journal of Tropical Medicine and Hygiene

Volumn 59, Issue 5, 1998, Pages 813-822

  Parise, Monica E ^c   Ayisi, John G ^a   Nahlen, Bernard L ^a   Schultz, Linda J ^a   Roberts, Jacquelin M ^a   Misore, Ambrose ^a   Muga, Richard ^a   Oloo, Aggrey J ^a   Steketee, Richard W ^b  

^a Mailstop E 45 ^*

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR;

ADULT; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; KENYA; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALARIA; NAUSEA; NEWBORN JAUNDICE; PARASITE PREVALENCE; PARASITE TRANSMISSION; PLACENTA DISORDER; PRIMIGRAVIDA; RASH; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; VOMITING;

EID: 0031786694     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.59.813     Document Type: Article

References (49)

1. McGregor IA, Wilson ME, Billewicz WZ, 1983. Malaria infection of the placenta in The Gambia, West Africa: its incidence and relationship to stillbirth, birth weight and placental weight. Trans R Soc Trop Med Hyg 77: 232-244.
2. Brabin BJ, 1983. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 61: 1005-1016.
3. Walter PR, Garin Y, Blot P, 1982. Placental pathologic changes in malaria. A histologic and ultrastructural study. Am J Pathol 109: 330-342.
4. Galbraith RM, Fox H, Hsi B, Galbraith GMP, Bray RS, Faulk WP, 1980. The human materno-foetal relationship in malaria. II. Histologic, ultrastructural and immunopathological studies of the placenta. Trans R Soc Trop Med Hyg 74: 61-72.
5. Yamada M, Steketee R, Abramowsky C, Kida M, Wirima J, Heymann D, Rabbege J, Breman J, Aikawa M, 1989. Plasmodium falciparum associated placental pathology: a light and electron microscopic and immunohistologic study. Am J Trop Med Hyg 41: 161-168.
6. Archibald HM, 1958. Influence of maternal malaria on newborn infants. Br Med J ii: 1512-1514.
7. Jilly P, 1969. Anaemia in parturient women, with special reference to malaria infection of the placenta. Ann Trop Med Parasitol 63: 109-116.
8. Cannon DSH, 1958. Malaria and prematurity in the western region of Nigeria. Br Med J ii: 877-878.
9. Gilles HM, Lawson JB, Sibelas M, Voller A, Allan N, 1969. Malaria, anaemia and pregnancy. Ann Trop Med Parasitol 63: 245-263.
10. Fleming AF, 1989. Tropical obstetrics and gynaecology. 1. Anaemia in pregnancy in tropical Africa. Trans R Soc Trop Med Hyg 83: 441-448.
11. Kaltreider DF, Johnson JWC, 1976. Patients at high risk for low-birth-weight delivery. Am J Obstet Gynecol 124: 251-256.
12. McCormick MC, 1985. The contribution of low birth weight to infant mortality and childhood morbidity. N Eng J Med 312: 82-90.
13. McGregor IA, 1984. Epidemiology, malaria and pregnancy. Am J Trop Med Hyg 33: 517-525.
14. Allen S, Lindan C, Serufilira A, Van de Peffe P. Rundle AC, Nsengumuremvi F, Carael M, Schwable J, Hulley S, 1991. Human immunodeficiency virus infection in urban Rwanda. JAMA 266: 1657-1663.
15. Wawer MJ, Serwadda D, Musgrave SD, Konde-Lule JK, Musagara M, Sewankambo NK, 1991. Dynamics of spread of HIV-I in a rural district of Uganda. Br Med J 303: 1303-1306.
16. Miotti PG, Delabetta G, Ndovi E, Liomba G, Saah AJ, Chiphangwi J, 1990. HIV-I and pregnant women: associated factors, prevalence, estimate of incidence and role in fetal wastage in central Africa. AIDS 4: 733-736.
17. Steketee RW, Wirima JJ, Bloland PB, Chilima B, Mermin JH, Chitsulo L, Breman JG, 1996. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1 Am J Trop Med Hyg 55 (suppl 1): 42-49.
18. Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG, 1995. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. AIDS 9: 721-726.
19. Navin TR, Miller KD, Satriale RF, Lobel HO, 1985. Adverse reactions associated with pyrimethamine-sulfadoxine for Pneumocystis carinii infections in AIDS (letter). Lancet i: 1322.
20. Centers for Disease Control and Prevention, 1988. Fansidar-associated fatal reaction in an HIV-infected man. MWWR Morb Mortal Wkly Rep 37: 571-573.
21. Bjorkman A, Phillips-Howard PA, 1991. Adverse reactions to sulfa drugs: implications for malaria chemotherapy. Bull World Health Organ 69: 297-304.
22. th Report. World Health Organ Tech Rep Ser 735.
23. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, Wirima JJ, 1994. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51: 515-522.
24. Beier JC, Perkins PV, Onyango FK, Gargan TP, Oster CN, Whitmire RE, Koech DK, Roberts CR, 1990. Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials. J Med Entomol 27: 570-577.
25. Spencer HC, Kaseje DCO, Koech DK, 1987. Community-based malaria control in Saradidi, Kenya: description of the programme and impact on parasitaemia rates and antimalarial antibodies. Ann Trop Med Parasitol 81 (suppl 1): 13-23.
26. Bloland PB, Lackritz EM, Kazembe PN, Were JBO, Steketee R, Campbell CC, 1993. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 167: 932-937.
27. Dubowitz LAS, Dubowitz V, Goldberg C, 1970. Clinical assessment of gestational age in the newborn infant. J Pediatr 77: 1-10.
28. Von Schenck H, Falkensson M, Lundberg B, 1986. Evaluation of "HemoCue," a new device for determining hemoglobin. Clin Chem 32: 526-529.
29. Mount DL, Nahlen BL, Patchen LC, Churchill FC, 1989. Adaptations of the SakerSolomons test: simple, reliable calorimetric field assays for chloroquine and its metabolites in urine. Bull World Health Organ 67: 295-300.
30. Mount DL, Green MD, Zucker JR, Were JBO, Todd GD, 1996. Field detection of sulfonamides in urine: the development of a new and sensitive test. Am J Trop Med Hyg 55: 250-253.
31. Steketee RW, Wirima JJ, Slutsker L, Roberts JM, Khoromana CO, Heymann DL, Breman JG, 1996. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi. Am J Trop Med Hyg 55 (suppl 1): 24-32.
32. Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Heymann DL, Breman JG, 1996. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine and mefloquine. Am J Trop Med Hyg 55 (suppl 1): 50-56.
33. Zucker JR, Lackritz EM, Ruebush II TK, Hightower AW, Adungosi JE, Were JBO, Metchock B, Patrick E, Campbell CC, 1996. Childhood mortality during and after hospitalization in western Kenya: effects of malaria treatment regimens. Am J Trop Med Hyg 55: 655-660.
34. Bowden FJ, Harman PJ, Lucas CR, 1986. Serum trimethoprim and sulphamethoxazole levels in AIDS. Lancet i: 853.
35. Steketee RW, Wirima JJ, Hightower AW, Slutsker L, Heymann DL, Breman JG, 1996. The effect of malaria and malaria prevention on offspring birth weight, prematurity, and intra-uterine growth retardation in rural Malawi. Am J Trop Med Hyg 55 (suppl 1): 33-41.
36. Miller KD, Lobel HO, Satriale RF, Kuritsky JN, Stern R, Campbell CC, 1986. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar®) for malaria prophylaxis. Am J Trop Med Hyg 35: 451-458.
37. Steketee RW, Wirima JJ, Campbell CC, 1996. Developing effective strategies for malaria prevention programs for pregnant African women. Am J Trop Med Hyg 55 (suppl 1): 95-100.
38. Nwanyanwu OC, Ziba C, Kazembe P, Chitsulo L, Wirima JJ, Kumwenda N, Redd SC, 1996. Efficacy of sulphadoxine/pyrimethamine for Plasmodium falciparum malaria in Malawian children under five years of age. Trop Med Int Health 1: 231-235.
39. Silverman WA, Andersen DH, Blanc WA, Crozier DN, 1956. A difference in mortality rate and incidence of kemicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 18: 614-625.
40. Dost FH, Gladtke E, 1969. Pharmacokinetics of 2-sulfamilamido-3-methoxy pyrazine in children (elimination, enteral absorption, distribution and dosage) (in German). Ameimittel-Forsching 19: 1304-1307.
41. Krauer B, Spring P, Dettli L, 1968. Zur Pharmakokinetik der sulfonamide im ersten Lebensjahr. Pharmacol Clin 1: 47-53.
42. Dunn PM, 1964. The possible relationship between the maternal administration of sulfamethoxypyridazine and hyperbilirubinemia in the newborn. J Obstet Gynaecol Br Commonwealth 71: 128-131.
43. Kantor HI, Sutherland DA, Leonard JT, Kamholz JH, Fry ND, White WL, 1961. Effect on bilirubin metabolism of sulfasoxazole administered to the mother. Obstet Gynecol 17: 494-500.
44. Drew JH, Kitchen WH, 1976. The effect of maternally administered drugs on bilirubin concentrations in the newborn infant. J Pediatr 89: 657-661.
45. Esbiomer E, Jamerot G, Wranne L, 1987. Sulphasalazine and sulphapyridine serum levels in children born to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr Scand 76: 137-142.
46. Morgan AD, Wenger NK, 1965. Sulfadiazine prophylaxis against rheumatic fever during pregnancy: its safety as regards the infant. J Med Assoc Ga 54: 153-154.
47. Baskin CG, Law S, Wenger NK, 1980. Sulfadiazine rheumatic fever prophylaxis during pregnancy: does it increase the risk of kemicterus in the newborn? Cardiology 65: 222-225.
48. Behrman, Vaughan III VC, 1983. Jaundice and hyperbilirubinemia in the newborn. Nelson WE, ed. Nelson Textbook of Pediatrics. Philadelphia: W. B. Saunders Co., 378.
49. National Council for Population and Development, Central Bureau of Statistics, Office of the Vice-President and Ministry of Planning and National Development, 1994. Kenya Demographic and Health Survey, 1993. Calverton, MD: Macro International Incorporated.